“SGLT2 Inhibitors: Cardiorenal Mechanisms How a Glucose-Lowering Drug Became a Foundational Heart and Kidney Therapy”. 2026. Diabzen 4 (14): 28-29. https://thediabzen.com/index.php/d/article/view/54.